FDA Approves Iobenguane I 131 for Rare Adrenal Gland Tumors

Intravenous Iobenguane I 131 has been approved to treat unresectable, locally advanced, or metastatic pheochromocytoma.

Source: CancerNetwork - August 7, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news